In addition to PD, LRRK2 has been reported to be associated with inflammatory bowel diseases (IBD) which is composed of two major subtypes, Crohn’s disease and ulcerative colitis, based on genome-wide association studies [46–49]. Here, LRRK2 is linked to ulcerative colitis.